Human papillomavirus (HPV) is a very big burden on women's health. It is known to cause cervical cancer, which is the second most common cancer worldwide among women. Laboratory studies have already demonstrated that Carrageenan is a potent inhibitor of HPV. "CATCH" stands for Carrageenan-gel Against Transmission of Cervical HPV infection. The goal of the CATCH Study is to evaluate the effectiveness of Carrageenan in reducing genital HPV infection in a population of young women, i.e., clearance and prevention of HPV. Results from CATCH will benefit STI prevention efforts in Canada and around the world.
ENROLMENT AND FOLLOW-UP COMPLETE! The CATCH study has successfully recruited its quota of 460+ women. After over seven years of dedicated and appreciated collaboration of all the people who took the time to enroll and contribute to the study, we have now reached critical capacity to gain useful knowledge to evaluate the effectiveness of Carrageenan in reducing genital HPV infection in a population of young women. Although data collection has been completed, CATCH datasets are still being used for analysis.
If you are interested in learning about our other studies, click here.